Evidence map›Paper›PMID 33009475›Full record

ArticleScientific reports2020

Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.

Pauline Gilson, Julien Levy, Marie Rouyer, Jessica Demange, Marie Husson, Céline Bonnet, Julia Salleron, Agnès Leroux, Jean-Louis Merlin, Alexandre Harlé

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Evaluation of the Idylla IDH1-2 Mutation Assay for the Detection ofInternational journal of molecular sciences · 2026
    Article
  6. Instability in the Penta-C and Penta-D Loci in Microsatellite-Unstable Endometrial Cancer.International journal of environmental research and public health · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Geographic and age-related variations in mutational processes in colorectal cancer.medRxiv : the preprint server for health sciences · 2025
    Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Pauline GilsonService de Biologie Moléculaire des Tumeurs, Institut de Cancérologie de Lorraine, CNRS UMR 7039 CRAN-Université de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France. p.gilson@nancy.unicancer.fr.
Julien LevyDépartement de Biopathologie, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Marie RouyerDépartement de Biopathologie, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Jessica DemangeDépartement de Biopathologie, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Marie HussonDépartement de Biopathologie, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Céline BonnetGenetics Laboratory, CHRU Nancy, rue du Morvan, 54511, Vandœuvre-lès-Nancy, France.
Julia SalleronDepartment of Biostatistics and Data Management, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Agnès LerouxDépartement de Biopathologie, Institut de Cancérologie de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Jean-Louis MerlinService de Biologie Moléculaire des Tumeurs, Institut de Cancérologie de Lorraine, CNRS UMR 7039 CRAN-Université de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Alexandre HarléService de Biologie Moléculaire des Tumeurs, Institut de Cancérologie de Lorraine, CNRS UMR 7039 CRAN-Université de Lorraine, 6 avenue de Bourgogne CS 30519, 54519, Vandœuvre-lès-Nancy Cedex, France.
Institut de Cancérologie de Lorraine · FRCentre de Recherche en Automatique de Nancy · FRCentre Hospitalier Régional et Universitaire de Nancy · FRCentre National de la Recherche Scientifique · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Microsatellite instability (MSI) status is routinely assessed in patients with colorectal and endometrial cancers as it contributes to Lynch syndrome initial screening, tumour prognosis and selecting patients for immunotherapy. Currently, standard reference methods recommended for MSI/dMMR (deficient MisMatch Repair) testing consist of immunohistochemistry and pentaplex PCR-based assays, however, novel molecular-based techniques are emerging. Here, we aimed to evaluate the performance of a custom capture-based NGS method and the Bio-Rad ddPCR and Idylla approaches for the determination of MSI status for theranostic purposes in 30 formalin-fixed paraffin embedded (FFPE) tissue samples from patients with endometrial (n = 15) and colorectal (n = 15) cancers. All samples were previously characterised using IHC and Promega MSI Analysis System and these assays set as golden standard. Overall agreement, sensitivity and specificity of our custom-built NGS panel were 93.30%, 93.75% and 92.86% respectively. Overall agreement, sensitivity and specificity were 100% with the Idylla MSI system. The Bio-Rad ddPCR MSI assay showed a 100% concordance, sensitivity and specificity. The custom capture-based NGS, Bio-Rad ddPCR and Idylla approaches represent viable and complementary options to IHC and Promega MSI Analysis System for the detection of MSI. Bio-Rad ddPCR and Idylla MSI assays accounts for easy and fast screening assays while the NGS approach offers the advantages to simultaneously detect MSI and clinically relevant genomic alterations.

Indexed as

Biomarkers, TumorColorectal NeoplasmsColorectal Neoplasms, Hereditary NonpolyposisDNA Mismatch RepairEndometrial NeoplasmsFemaleFormaldehydeHigh-Throughput Nucleotide SequencingHumansImmunohistochemistryMicrosatellite InstabilityPatientsPolymerase Chain ReactionPrognosisSensitivity and SpecificityTissue FixationBiomarkers, TumorFormaldehyde

Identifiers

PMID33009475
PMCPMC7532161
OpenAlexW3090609172

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.